Tasos Konidaris insider trades
Open-market stock purchases and sales by Tasos Konidaris, Executive Vice President & CFO at Amneal Pharmaceuticals, Inc, from SEC Form 4 filings since Feb 11, 2010.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Mar 4, 2026 | AMRX Amneal Pharmaceuticals, Inc | Bought (not open market) | — |
| Mar 4, 2026 | AMRX Amneal Pharmaceuticals, Inc | Sold (not open market) | $293K |
| Mar 4, 2026 | AMRX Amneal Pharmaceuticals, Inc | Bought (not open market) | — |
| Mar 3, 2026 | AMRX Amneal Pharmaceuticals, Inc | Sold (not open market) | $3.1M |
| Mar 3, 2026 | AMRX Amneal Pharmaceuticals, Inc | Bought (not open market) | — |
| Mar 3, 2026 | AMRX Amneal Pharmaceuticals, Inc | Bought (not open market) | — |
| Mar 3, 2026 | AMRX Amneal Pharmaceuticals, Inc | Sold (not open market) | $215K |
| Mar 3, 2026 | AMRX Amneal Pharmaceuticals, Inc | Sold (not open market) | $323K |
| Mar 3, 2026 | AMRX Amneal Pharmaceuticals, Inc | Sold (not open market) | $190K |
| Mar 3, 2026 | AMRX Amneal Pharmaceuticals, Inc | Bought (not open market) | — |
| Mar 3, 2026 | AMRX Amneal Pharmaceuticals, Inc | Bought (not open market) | — |
| Mar 2, 2026 | AMRX Amneal Pharmaceuticals, Inc | Bought (not open market) | — |
Companies traded
- AMRX Amneal Pharmaceuticals, Inc: 4 sales, last Mar 4, 2026
- KDMN Kadmon Holdings, Inc: other filings, last Nov 9, 2021
- PTX Pernix Therapeutics Holdings, Inc: other filings, last May 26, 2016
- DCTH Delcath Systems, Inc: other filings, last Jul 7, 2014
- DNB DUN & Bradstreet Corp/nw: other filings, last Mar 16, 2011